Dr. Barry Dworkin

Not “game-changing” but another positive step forward for evidenced-based treatment to help people with #Overweight or #Obesity.

Sunday House Call, #777, February 14, 2021

This week the NEJM published a study concluding “In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight.”

A follow up editorial provides some perspective.

Your calls about:

  • Can mouthwash and nasal rinses prevent Covid-19 infections?
  • What are the clinical indications for intubation?
  • The appearance of variants in Canada and around the world. Do they share similar mutations?
  • Blood pressure checks.

References:
A discussion with the co-author of Canada’s weight management guidelines Dr. Sean Wharton

Dr. David Macklin discusses what we know about the influences on our appetite and weight.

Related posts:

  1. It is not only obesity that affects health risk
  2. Sunday House Call, #386, February 26, 2012
  3. Sunday House Call, #815, November 14, 2021: @YoniFreedhoff discusses “2021’s dumbest scientifically published exercise recommendation for the treatment of obesity” and what works in reality.
  4. Treatments for weight loss do exist, work well for many, and reveal our growing understanding of how our homeostatic, motivational, and executive brain centers interact with respect to weight control.